WeVote

Bill

Bill

SB 749

AN ACT CLASSIFYING XYLAZINE AS A SCHEDULE IV CONTROLLED SUBSTANCE.

2025 Regular Session Introduced by Saud Anwar

Connecticut bill would classify xylazine as Schedule IV controlled substance to address its emergence in illicit drug supplies and combat trafficking.

REF. TO JOINT COMM. ON General Law
0
WeVote Research Nonpartisan
Bill Summary · SB 749

Legislative bill overview

SB 749 would classify xylazine as a Schedule IV controlled substance under Connecticut law. Xylazine is a veterinary tranquilizer increasingly found in illicit drug supplies, particularly mixed with opioids and fentanyl. This classification would establish legal penalties for unauthorized possession, distribution, and manufacturing of the substance.

Why is this important

Xylazine has emerged as a significant public health concern, appearing in street drug supplies and complicating overdose treatment since it doesn't respond to naloxone (Narcan). Scheduling it would provide law enforcement with regulatory tools and could deter trafficking, while also signaling public health priorities around emerging drug threats that standard overdose reversal methods cannot address.

Potential points of contention

  • Medical use restrictions: Schedule IV classification could complicate legitimate veterinary and medical research uses, potentially requiring additional licensing and creating supply chain complications for veterinary practitioners
  • Effectiveness questions: Critics may argue that scheduling addresses symptoms rather than root causes of drug contamination, and that harm reduction approaches (testing supplies, medical supervision) might be more effective than criminalization
  • Sentencing disparities: Adding another drug to the controlled substances list could contribute to criminal justice system burdens and raise concerns about whether criminal penalties are proportionate compared to treatment-focused alternatives for individuals struggling with substance use

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.